Serina Therapeutics, Inc. Income Statement
SER|7 years of annual SEC 10-K data (FY2018-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$130,000
FY2025
Gross Profit
N/A
FY2025
Operating Income
-$24M
FY2025
Net Income
-$19M
FY2025
Serina Therapeutics, Inc. reported $130,000 in revenue and $19M in net loss for FY2025. Revenue has declined at a 28.8% compound annual rate over the past 7 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 |
|---|---|---|---|---|---|---|---|
| Revenue | $130.0K | $3.2M | $3.2M | $34.0K | $144.0K | $1.7M | $1.4M |
| Cost of Revenue | - | - | $40.0K | $13.0K | $19.0K | $244.0K | $364.0K |
| Gross Profit | - | - | $102.0K | $21.0K | $125.0K | $1.5M | $1.0M |
| SG&A Expense | $11.0M | $3.9M | $3.9M | $6.0M | $6.7M | $8.1M | $5.6M |
| R&D Expense | $13.2M | $2.4M | $2.4M | $1.0M | $1.5M | $5.9M | $5.8M |
| Operating Income | -$24.0M | -$3.1M | -$3.1M | -$7.0M | -$7.9M | -$12.6M | -$11.2M |
| Interest Expense | - | - | $4.9M | $3.3M | $1.1M | - | - |
| Income Tax | $18.0K | $0 | $0 | - | - | $148.0K | - |
| Net Income | -$19.2M | $5.3M | $5.3M | -$10.5M | -$8.7M | -$12.2M | -$7.5M |
| EPS (Basic) | -$1.51 | $2.36 | -$9.70 | -$0.23 | - | - | - |
| EPS (Diluted) | -$1.51 | $0.73 | -$9.70 | - | -$0.29 | -$0.33 | -$0.21 |
| Shares Outstanding | 8.4M | 2.4M | 1.1M | 37.9M | 37.7M | 37.6M | 33.8M |
| Gross Margin | - | - | 3.2% | 61.8% | 86.8% | 85.9% | 73.9% |
| Operating Margin | -18478.5% | -99.2% | -99.2% | -20514.7% | -5509.0% | -726.8% | -805.5% |
| Profit Margin | -14755.4% | 167.1% | 167.1% | -30770.6% | -6024.3% | -703.4% | -537.4% |